Rowela Mallare retweetledi

At #SABCS 2024, check out the late-breaking oral presentation of Phase 3 data for our CDK4/6i in combination with standard-of-care therapy in HR+/HER2+ metastatic #BreastCancer. View the presentation here: bit.ly/3YU7t7k

English


















